These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32597132)

  • 1. In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
    Rozenek EB; Górska M; Wilczyńska K; Waszkiewicz N
    Arh Hig Rada Toksikol; 2019 Sep; 70(3):150-159. PubMed ID: 32597132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychostimulants and cognition: a continuum of behavioral and cognitive activation.
    Wood S; Sage JR; Shuman T; Anagnostaras SG
    Pharmacol Rev; 2014; 66(1):193-221. PubMed ID: 24344115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.
    Gehring K; Patwardhan SY; Collins R; Groves MD; Etzel CJ; Meyers CA; Wefel JS
    J Neurooncol; 2012 Mar; 107(1):165-74. PubMed ID: 21964738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
    Repantis D; Schlattmann P; Laisney O; Heuser I
    Pharmacol Res; 2010 Sep; 62(3):187-206. PubMed ID: 20416377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine.
    Roberts CA; Jones A; Sumnall H; Gage SH; Montgomery C
    Eur Neuropsychopharmacol; 2020 Sep; 38():40-62. PubMed ID: 32709551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
    Leijenaar JF; Groeneveld GJ; Klaassen ES; Leeuwis AE; Scheltens P; Weinstein HC; van Gerven JMA; Barkhof F; van der Flier WM; Prins ND
    Alzheimers Res Ther; 2020 Jan; 12(1):10. PubMed ID: 31910895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.
    Alam N; Choudhary K
    Metab Brain Dis; 2018 Jun; 33(3):893-906. PubMed ID: 29470766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
    Sahakian BJ; Morein-Zamir S
    Lancet Psychiatry; 2015 Apr; 2(4):357-62. PubMed ID: 26360089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Students' stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation.
    Ponnet K; Tholen R; De Bruyn S; Wouters E; Van Ouytsel J; Walrave M; Van Hal G
    Drug Alcohol Depend; 2021 Jan; 218():108410. PubMed ID: 33250387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
    Fond G; Micoulaud-Franchi JA; Brunel L; Macgregor A; Miot S; Lopez R; Richieri R; Abbar M; Lancon C; Repantis D
    Psychiatry Res; 2015 Sep; 229(1-2):12-20. PubMed ID: 26187342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of stimulants in depression: Results from a self-controlled register study.
    Rohde C; Brink P; Østergaard SD; Nielsen J
    Aust N Z J Psychiatry; 2020 Aug; 54(8):808-817. PubMed ID: 32447969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
    Kapur A
    CNS Drugs; 2020 Oct; 34(10):1045-1062. PubMed ID: 32794136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.
    Busardò FP; Kyriakou C; Cipolloni L; Zaami S; Frati P
    Curr Neuropharmacol; 2016; 14(1):17-27. PubMed ID: 26813119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
    Advokat C
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1256-66. PubMed ID: 20381522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
    Bagot KS; Kaminer Y
    Addiction; 2014 Apr; 109(4):547-57. PubMed ID: 24749160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
    J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.
    Franke AG; Gränsmark P; Agricola A; Schühle K; Rommel T; Sebastian A; Balló HE; Gorbulev S; Gerdes C; Frank B; Ruckes C; Tüscher O; Lieb K
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):248-260. PubMed ID: 28119083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.